Centene Earnings: Medicare Margin Improvement Boosts 2026 Guidance
Centene's third-quarter results included 2% revenue growth, a steady 92.7% medical cost ratio, and adjusted earnings per share of $0.58, well above the FactSet consensus of $0.10. Management raised its adjusted EPS outlook by $0.40 to at least $5.20 in 2026 and said it expects growth in 2027.